Difference between revisions of "Pracinostat (SB-939)"
Jump to navigation
Jump to search
m |
m |
||
| Line 16: | Line 16: | ||
[[Category:HDAC inhibitors]] | [[Category:HDAC inhibitors]] | ||
| − | [[Category:Acute myeloid leukemia medications]] | + | [[Category:Acute myeloid leukemia medications (investigational)]] |
| + | |||
| + | [[Category:Investigational drugs]] | ||
Revision as of 01:58, 26 April 2022
Mechanism of action
HDAC inhibitor
History of changes in FDA indication
- 2/27/2014: Granted FDA orphan drug status for treatment of acute myeloid leulemia.
Also known as
- Code name: SB939